Detection of Pseudomonas aeruginosa in exhaled breath of cystic fibrosis patients

A. Neerincx (Amsterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), P. Van Der Gouwe (Amsterdam, Netherlands), T. Paff (Amsterdam, Netherlands), N. Fens (Amsterdam, Netherlands), M. Gerritsen (Amsterdam, Netherlands), E. Haarman (Amsterdam, Netherlands), W. Van Aalderen (Amsterdam, Netherlands), C. Majoor (Amsterdam, Netherlands), E. Weersink (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands), A. Maitland-Van Der Zee & The Amsterdam Cf Research Group (Amsterdam, Netherlands)

Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Session: Cystic fibrosis: microbiological aspects and new treatments
Session type: Oral Presentation
Number: 511
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Neerincx (Amsterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), P. Van Der Gouwe (Amsterdam, Netherlands), T. Paff (Amsterdam, Netherlands), N. Fens (Amsterdam, Netherlands), M. Gerritsen (Amsterdam, Netherlands), E. Haarman (Amsterdam, Netherlands), W. Van Aalderen (Amsterdam, Netherlands), C. Majoor (Amsterdam, Netherlands), E. Weersink (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands), A. Maitland-Van Der Zee & The Amsterdam Cf Research Group (Amsterdam, Netherlands). Detection of Pseudomonas aeruginosa in exhaled breath of cystic fibrosis patients. 511

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020


Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis
Source: ERJ Open Res 2015; 1: 00044-2015
Year: 2015



Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018




Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis
Source: Eur Respir J 2011; 37: 553-558
Year: 2011



Does sputum induction improve Pseudomonas aeruginosa detection in cystic fibrosis?
Source: Eur Respir J 2003; 22: Suppl. 45, 231s
Year: 2003

Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis
Source: Eur Respir J 2004; 24 : 631-637
Year: 2004



Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis
Source: Eur Respir J 2007; 30: 286-292
Year: 2007



The sensitivity and specificity of pseudomonas aeruginosa detection using hydrogen cyanide concentration in exhaled breath – The SPACE study
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014


Eradication of Pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2006; 27: 653
Year: 2006


Detection of antibodies against Pseudomonas aeruginosa in the sputum of cystic fibrosis patients: A pilot study
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012

Chest physiotherapy enhances detection of Pseudomonas aeruginosa in nonexpectorating children with cystic fibrosis
Source: ERJ Open Res, 7 (1) 00513-2020; 10.1183/23120541.00513-2020
Year: 2021



Antibodies against Pseudomonas aeruginosa in patients with cystic fibrosis – clinical application
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018

The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis
Source: Eur Respir J 2006; 28: 974-979
Year: 2006



Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2003; 22: 503-506
Year: 2003



Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
Source: Eur Respir J , 49 (4)  1602108; DOI: 10.1183/13993003.02108-2016
Year: 2017




Mucoid Pseudomonas aeruginosa alter sputum viscoelastic properties in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019


Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 379s
Year: 2002

Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Source: Eur Respir J 2008; 31: 822-829
Year: 2008



Does mass spectrometric breath analysis detect Pseudomonas aeruginosa in cystic fibrosis?
Source: Eur Respir J 2016; 47: 994-997
Year: 2016